A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 196 participants.
Also called NCT03254485
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 196 participants
- Sponsor
- Registry
-
NCT03254485
-
- Other papers using this trial's data
- Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT03254485. Randomized; quadruple masking; primary purpose treatment. Start 2017-11-07 (actual); primary completion 2019-08-19 (actual). Results posted on 2022-09-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
- Acronym
- CAPACITY-HFpEF
- Intervention (Drug)
- IW-1973
- Intervention (Drug)
- Placebo Oral Tablet
- Lead sponsor
- Akebia Therapeutics
- Collaborator
- Cyclerion Therapeutics
Record details
- Record id
cardio:ct-nct03254485- Content hash
e6aede9199708fac85b20d1f7f526e9022d93905c1431e599af5aea609b87cc1